333 related articles for article (PubMed ID: 24409320)
1. Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging.
Vormoor B; Knizia HK; Batey MA; Almeida GS; Wilson I; Dildey P; Sharma A; Blair H; Hide IG; Heidenreich O; Vormoor J; Maxwell RJ; Bacon CM
PLoS One; 2014; 9(1):e85128. PubMed ID: 24409320
[TBL] [Abstract][Full Text] [Related]
2. A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma.
Luo W; Hoang H; Liao Y; Pan J; Ayello J; Cairo MS
Front Immunol; 2023; 14():1277987. PubMed ID: 37868989
[TBL] [Abstract][Full Text] [Related]
3. Successful high-resolution animal positron emission tomography of human Ewing tumours and their metastases in a murine xenograft model.
Franzius C; Hotfilder M; Poremba C; Hermann S; Schäfers K; Gabbert HE; Jürgens H; Schober O; Schäfers M; Vormoor J
Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1432-41. PubMed ID: 16896672
[TBL] [Abstract][Full Text] [Related]
4. The role of imaging of malignant bone tumors in children and young adults.
Rana KA; Meyer J; Ibrahim S; Ralls M; Kent PM
Curr Probl Cancer; 2013; 37(4):181-91. PubMed ID: 24238583
[No Abstract] [Full Text] [Related]
5. Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imaging.
Liebsch L; Kailayangiri S; Beck L; Altvater B; Koch R; Dierkes C; Hotfilder M; Nagelmann N; Faber C; Kooijman H; Ring J; Vieth V; Rossig C
Br J Cancer; 2013 Aug; 109(3):658-66. PubMed ID: 23839490
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
[TBL] [Abstract][Full Text] [Related]
7. MRI of primary lymphoma of bone: cortical disorder as a criterion for differential diagnosis.
Häussler MD; Fenstermacher MJ; Johnston DA; Harle TS
J Magn Reson Imaging; 1999 Jan; 9(1):93-100. PubMed ID: 10030656
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice.
Marques da Costa ME; Daudigeos-Dubus E; Gomez-Brouchet A; Bawa O; Rouffiac V; Serra M; Scotlandi K; Santos C; Geoerger B; Gaspar N
Cancer Med; 2018 Mar; 7(3):665-676. PubMed ID: 29473324
[TBL] [Abstract][Full Text] [Related]
9. The sensitivity, specificity, and diagnostic accuracy of whole-bone MRI for identifying skip metastases in appendicular osteosarcoma and Ewing sarcoma.
Barnett JR; Gikas P; Gerrand C; Briggs TW; Saifuddin A
Skeletal Radiol; 2020 Jun; 49(6):913-919. PubMed ID: 31900513
[TBL] [Abstract][Full Text] [Related]
10. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H
AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251
[TBL] [Abstract][Full Text] [Related]
11. Metastasis Assessment in Ewing Sarcoma Using Orthotopic Xenografts.
López-Alemany R; Tirado OM
Methods Mol Biol; 2021; 2226():201-213. PubMed ID: 33326104
[TBL] [Abstract][Full Text] [Related]
12. [Interdisciplinary diagnostic and treatment of bone sarcomas of the extremities and trunk].
Andreou D; Hardes J; Gosheger G; Henrichs MP; Nottrott M; Streitbürger A
Handchir Mikrochir Plast Chir; 2015 Apr; 47(2):90-9. PubMed ID: 25897578
[TBL] [Abstract][Full Text] [Related]
13. Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee.
Meyer JS; Nadel HR; Marina N; Womer RB; Brown KL; Eary JF; Gorlick R; Grier HE; Randall RL; Lawlor ER; Lessnick SL; Schomberg PJ; Kailo MD
Pediatr Blood Cancer; 2008 Aug; 51(2):163-70. PubMed ID: 18454470
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of primary malignant bone tumors.
Bloem JL; Bluemm RG; Taminiau AH; van Oosterom AT; Stolk J; Doornbos J
Radiographics; 1987 May; 7(3):425-45. PubMed ID: 3482329
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of osteosarcoma in a patient previously treated for Ewing sarcoma.
Hoshi M; Ieguchi M; Yamato K; Tokimasa S; Nakamura H
Skeletal Radiol; 2014 Sep; 43(9):1319-24. PubMed ID: 24722657
[TBL] [Abstract][Full Text] [Related]
16. Primary skeletal neoplasms: osteosarcoma and ewing sarcoma.
Hoffer FA
Top Magn Reson Imaging; 2002 Aug; 13(4):231-9. PubMed ID: 12409691
[TBL] [Abstract][Full Text] [Related]
17. Update on imaging and treatment of Ewing sarcoma family tumors: what the radiologist needs to know.
Mar WA; Taljanovic MS; Bagatell R; Graham AR; Speer DP; Hunter TB; Rogers LF
J Comput Assist Tomogr; 2008; 32(1):108-18. PubMed ID: 18303298
[TBL] [Abstract][Full Text] [Related]
18. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.
O'Neill AF; Dearling JL; Wang Y; Tupper T; Sun Y; Aster JC; Calicchio ML; Perez-Atayde AR; Packard AB; Kung AL
Clin Cancer Res; 2014 Feb; 20(3):678-87. PubMed ID: 24218512
[TBL] [Abstract][Full Text] [Related]
19. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours.
Györke T; Zajic T; Lange A; Schäfer O; Moser E; Makó E; Brink I
Nucl Med Commun; 2006 Jan; 27(1):17-24. PubMed ID: 16340719
[TBL] [Abstract][Full Text] [Related]
20. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
